James Armitage

James Armitage

Director/Board Member chez TESARO INC

Fortune : 146 797 $ au 31/03/2024

77 ans
Health Technology
Consumer Services
Health Services

Profil

James O.
Armitage
is currently the Director at Tesaro, Inc., the Independent Director at Cardiff Oncology, Inc., and a Professor-Internal Medicine at the University of Nebraska Medical Center.
Previously, he served as the Director at MGI PHARMA, Inc. from 2006 to 2008.
He also held positions as the President & Director of the American Society of Clinical Oncology, Inc. and as the President of the American Society for Blood & Marrow Transplantation.
Dr. Armitage obtained his undergraduate degree from the University of Nebraska and his doctorate from the University of Nebraska Medical Center.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
15/06/2023 27 490 ( 0,06% ) 146 797 $ 31/03/2024

Postes actifs de James Armitage

SociétésPosteDébut
TESARO INC Director/Board Member 09/05/2013
CARDIFF ONCOLOGY, INC. Director/Board Member 22/04/2020
University of Nebraska Medical Center Corporate Officer/Principal 01/01/1982
Tous les postes actifs de James Armitage

Anciens postes connus de James Armitage

SociétésPosteFin
Director/Board Member 29/01/2008
American Society for Blood & Marrow Transplantation President -
President -
Voir l'expérience en détail de James Armitage

Formation de James Armitage

University of Nebraska Undergraduate Degree
University of Nebraska Medical Center Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de James Armitage

Relations

96

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
CARDIFF ONCOLOGY, INC.

Health Technology

Entreprise privées4

Health Technology

Health Technology

Health Services

American Society for Blood & Marrow Transplantation

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. James Armitage